Your browser doesn't support javascript.
loading
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
Le Saux, Olivia; Lardy-Cleaud, Audrey; Frank, Sophie; Debled, Marc; Cottu, Paul H; Pistilli, Barbara; Vanlemmens, Laurence; Leheurteur, Marianne; Lévy, Christelle; Laborde, Lilian; Uwer, Lionel; D'hondt, Veronique; Berchery, Delphine; Lorgis, Veronique; Ferrero, Jean-Marc; Perrocheau, Genevieve; Courtinard, Coralie; Mouret-Reynier, Marie Ange; Velten, Michel; Breton, Mathias; Parent, Damien; Chabaud, Sylvie; Robain, Mathieu; Bachelot, Thomas.
Afiliación
  • Le Saux O; Department of Medical Oncology, Léon Bérard Centre, Lyon, France. Electronic address: olivia.lesaux@gmail.com.
  • Lardy-Cleaud A; Department of Medical Oncology, Léon Bérard Centre, Lyon, France.
  • Frank S; Department of Medical Oncology, Curie Institute, Paris, France.
  • Debled M; Department of Medical Oncology, Bergonié Institute, Bordeaux, France.
  • Cottu PH; Department of Medical Oncology, Curie Institute, Paris, France.
  • Pistilli B; Breast Cancer Unit, Gustave Roussy Institute, Villejuif, France.
  • Vanlemmens L; Breast Unit, Oscar Lambret Centre, Lille, France.
  • Leheurteur M; Department of Oncology, Henri Becquerel Centre, Rouen, France.
  • Lévy C; Cancers & Preventions, François Baclesse Centre, Caen, France.
  • Laborde L; Data Management and Analysis Center, Paoli-Calmettes Institute, Marseille, France.
  • Uwer L; Department of Medical Oncology, Alexis-Vautrin Cancer Institute of Lorraine, Vandœuvre-lès-Nancy, France.
  • D'hondt V; Department of Medical Oncology, Montpellier Regional Cancer Institute, Montpellier, France.
  • Berchery D; Department of Medical Information, Claudius Regaud Institute, Toulouse, France.
  • Lorgis V; Department of Medical Oncology, Georges-François-Leclerc Centre, Dijon, France.
  • Ferrero JM; Department of Medical Oncology, Antoine Lacassagne Cancer Center, Nice, France.
  • Perrocheau G; Clinical Investigation Centre, René Gauducheau Centre, Saint-Herblain, France.
  • Courtinard C; Department of Research and Development, R&D Unicancer, Paris, France.
  • Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand, France.
  • Velten M; Department of Epidemiology and Biostatistics, Centre Paul Strauss, Strasbourg, France.
  • Breton M; Medical Information Department, Centre Eugéne Marquis, Rennes, France.
  • Parent D; Department of Pharmacy, Institut de Cancérologie Jean-Godinot, Reims, France.
  • Chabaud S; Department of Medical Oncology, Léon Bérard Centre, Lyon, France.
  • Robain M; Department of Research and Development, R&D Unicancer, Paris, France.
  • Bachelot T; Department of Medical Oncology, Léon Bérard Centre, Lyon, France.
Eur J Cancer ; 118: 131-141, 2019 09.
Article en En | MEDLINE | ID: mdl-31330488
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Progesterona / Receptores de Estrógenos / Biomarcadores de Tumor / Receptor ErbB-2 / Antineoplásicos Hormonales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptores de Progesterona / Receptores de Estrógenos / Biomarcadores de Tumor / Receptor ErbB-2 / Antineoplásicos Hormonales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2019 Tipo del documento: Article